Transcatheter Cardiac Pacemaker Market Size By
position, By End User, Industry Analysis Report,
Regional Outlook and Forecast, 2017 – 2024: Global
Market Insights Inc.
Transcatheter Cardiac Pacemaker Market system determines the slow or irregular heart
rhythms (arrhythmias) with single chamber pacemaker system. It provides an
alternative to traditional pacing systems by removing the necessity for permanent
transvenous leads while offering therapy for bradyarrhythmias. Restriction to single-
chamber ventricular pacing will restrain the industry growth.
Remarkable increase in the number of cardiac procedures with leadless pacemaker has
been observed. It eliminates the serious complications arises with traditional devices,
once the implanted leads get infected or wear out. Investment by healthcare providers
on technological advancements, increase in the patient lifespan and improvement in the
quality of life, high occurrence and mortality rates associated with cardiac
conditions and development of innovative pacemakers will further rise the demand for
leadless devices.
Implementation of leadless pacemaker in cardiac surgery is increased due to its MRI
compatibility, endeavor to enhance and facilitate the process when bradycardic
conditions exist. Advancement in transcatheter process coupled with minimally
invasive procedure, reduction in the surgical risks and possible complications,
government initiatives for enhancing reimbursement policies, shorter implantation
procedure and reduced recovery time will uplift the product demand. Additionally,
increasing obesity, changing life style, physical inactivity will fuel the industry share in
the coming years.
The FDA regulates the device under the Medical Devices Act. The Centers for Medicare
& Medicaid Services (CMS) offers coverage for the Medtronic Micra Transcatheter
Pacing System through Coverage with Evidence Development (CED).
Based on position of pacemaker the industry can be segmented into left ventricle and
right ventricle. Right ventricle holds major share due to the prevalence of arrhythmias
in right ventricle in comparison to left ventricle. Based on end use the industry can be
segmented in hospitals and clinics. Hospital segment is likely to lead the industry due to
availability of cost-effective cardiac procedure witnessing a lucrative growth over the
forecasted period.
1 | Page